Meanwhile, IL-33 is expressed in both cancer cells and stromal cells in the HCC microenvironment, which may be a key tumor promoter for HCC proliferation and tumorigenicity and negatively correlates with survival of HCC patients [134, 135]. This evidence concerns the gene IL33 and hepatocellular carcinoma.